Invertebrate Models Untangle the Mechanism of Neurodegeneration in Parkinson’s Disease
Parkinson’s disease (PD) is the second most common neurodegenerative disease, afflicting ~10 million people worldwide. Although several genes linked to PD are currently identified, PD remains primarily an idiopathic disorder. Neuronal protein α-synuclein is a major player in disease progression of b...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/2/407 |
id |
doaj-7d4b3d41519f47bcb64afe9e09bb35cb |
---|---|
record_format |
Article |
spelling |
doaj-7d4b3d41519f47bcb64afe9e09bb35cb2021-02-17T00:02:41ZengMDPI AGCells2073-44092021-02-011040740710.3390/cells10020407Invertebrate Models Untangle the Mechanism of Neurodegeneration in Parkinson’s DiseaseAndrei Surguchov0Department of Neurology, University of Kansas Medical Center, Kansas City, KS 66160, USAParkinson’s disease (PD) is the second most common neurodegenerative disease, afflicting ~10 million people worldwide. Although several genes linked to PD are currently identified, PD remains primarily an idiopathic disorder. Neuronal protein α-synuclein is a major player in disease progression of both genetic and idiopathic forms of PD. However, it cannot alone explain underlying pathological processes. Recent studies demonstrate that many other risk factors can accelerate or further worsen brain dysfunction in PD patients. Several PD models, including non-mammalian eukaryotic organisms, have been developed to identify and characterize these factors. This review discusses recent findings in three PD model organisms, i.e., yeast, Drosophila, and <i>Caenorhabditis elegans</i>, that opened new mechanisms and identified novel contributors to this disorder. These non-mammalian models share many conserved molecular pathways and cellular processes with humans. New players affecting PD pathogenesis include previously unknown genes/proteins, novel signaling pathways, and low molecular weight substances. These findings might respond to the urgent need to discover novel drug targets for PD treatment and new biomarkers for early diagnostics of this disease. Since the study of neurodegeneration using simple eukaryotic organisms brought a huge amount of information, we include only the most recent or the most important relevant data.https://www.mdpi.com/2073-4409/10/2/407neurodegenerationprotein aggregationprotein sortingalpha-synucleinvesicular traffickingfolate |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Andrei Surguchov |
spellingShingle |
Andrei Surguchov Invertebrate Models Untangle the Mechanism of Neurodegeneration in Parkinson’s Disease Cells neurodegeneration protein aggregation protein sorting alpha-synuclein vesicular trafficking folate |
author_facet |
Andrei Surguchov |
author_sort |
Andrei Surguchov |
title |
Invertebrate Models Untangle the Mechanism of Neurodegeneration in Parkinson’s Disease |
title_short |
Invertebrate Models Untangle the Mechanism of Neurodegeneration in Parkinson’s Disease |
title_full |
Invertebrate Models Untangle the Mechanism of Neurodegeneration in Parkinson’s Disease |
title_fullStr |
Invertebrate Models Untangle the Mechanism of Neurodegeneration in Parkinson’s Disease |
title_full_unstemmed |
Invertebrate Models Untangle the Mechanism of Neurodegeneration in Parkinson’s Disease |
title_sort |
invertebrate models untangle the mechanism of neurodegeneration in parkinson’s disease |
publisher |
MDPI AG |
series |
Cells |
issn |
2073-4409 |
publishDate |
2021-02-01 |
description |
Parkinson’s disease (PD) is the second most common neurodegenerative disease, afflicting ~10 million people worldwide. Although several genes linked to PD are currently identified, PD remains primarily an idiopathic disorder. Neuronal protein α-synuclein is a major player in disease progression of both genetic and idiopathic forms of PD. However, it cannot alone explain underlying pathological processes. Recent studies demonstrate that many other risk factors can accelerate or further worsen brain dysfunction in PD patients. Several PD models, including non-mammalian eukaryotic organisms, have been developed to identify and characterize these factors. This review discusses recent findings in three PD model organisms, i.e., yeast, Drosophila, and <i>Caenorhabditis elegans</i>, that opened new mechanisms and identified novel contributors to this disorder. These non-mammalian models share many conserved molecular pathways and cellular processes with humans. New players affecting PD pathogenesis include previously unknown genes/proteins, novel signaling pathways, and low molecular weight substances. These findings might respond to the urgent need to discover novel drug targets for PD treatment and new biomarkers for early diagnostics of this disease. Since the study of neurodegeneration using simple eukaryotic organisms brought a huge amount of information, we include only the most recent or the most important relevant data. |
topic |
neurodegeneration protein aggregation protein sorting alpha-synuclein vesicular trafficking folate |
url |
https://www.mdpi.com/2073-4409/10/2/407 |
work_keys_str_mv |
AT andreisurguchov invertebratemodelsuntanglethemechanismofneurodegenerationinparkinsonsdisease |
_version_ |
1724265913175244800 |